Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

As seasons change, increased itching can occur; hydrate, moisturize, and choose soft fabrics to alleviate discomfort ...

While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Pfizer's booth at the China International Import Expo in Shanghai, Nov. 7, 2024. [Photo by Wang Yiming/China.org.cn] Pfizer ...

The study compared the risk and cumulative incidence of requiring glaucoma surgery—such as minimally invasive surgery, ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

The unique feline dermatological cases veterinary professionals can see at the clinic, plus how to approach them ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...